节点文献

菌群异常在帕金森病病情进展及治疗中的研究

Study of abnormal microflora in progression and treatment of Parkinson’s disease

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 岳欣毅周庆博

【Author】 Yue Xinyi;Zhou Qingbo;Cheeloo College of Medicine, Shandong University;

【通讯作者】 周庆博;

【机构】 山东大学齐鲁医学院山东大学第二医院神经内科

【摘要】 帕金森病是老年人第二大常见的神经退行性疾病,最新研究为帕金森病肠道起源假说提供了证据,肠道菌群可通过肠道和大脑间的双向通信影响中枢神经系统。菌群异常通过引起α-突触核蛋白异常聚集在帕金森病中发挥重要作用,帕金森药物与肠道菌群可相互影响,特异菌群与帕金森病临床特征相关,改善肠道菌群组成可降低帕金森病发病风险,延缓疾病进程。该文对帕金森病菌群异常的病理生理、临床特征及治疗方面进行了综述。

【Abstract】 Parkinson’s disease is the second most common neurodegenerative disease in the elderly population. Recent research provides evidence for the hypothesis of the intestinal origin of Parkinson’s disease. Intestinal flora can affect the central nervous system through two-way communication between the gut and brain. Abnormal microflora plays an important role in Parkinson’s disease by causing abnormal aggregation of α-synuclein. Parkinson’s disease drugs can interact with intestinal microflora, and specific microflora is related to clinical characteristics of Parkinson’s disease. Improving the composition of intestinal microflora can reduce the risk of Parkinson’s disease and delay the disease progression. In this article, the pathophysiology, clinical features and treatment of abnormal microflora in Parkinson’s disease were reviewed.

【基金】 山东省自然科学基金项目(ZR2021MH098)
  • 【文献出处】 新医学 ,Journal of New Medicine , 编辑部邮箱 ,2023年05期
  • 【分类号】R742.5
  • 【下载频次】45
节点文献中: 

本文链接的文献网络图示:

本文的引文网络